Image may be NSFW.
Clik here to view.
Valeritas (NSDQ:VLRX) said today that it inked an exclusive distribution deal with AMSL Diabetes and NZMS Diabetes for the commercialization of its V-Go wearable insulin delivery device in Australia and New Zealand.
According to the terms of the agreement, AMSL Diabetes and NZMS Diabetes retain the right to promote, market and sell the V-Go device to clinics and patients, while Valeritas remains responsible for regulatory and manufacturing activities. Financial terms of the deal were not disclosed.
Get the full story at our sister site, Drug Delivery Business News.
The post Valeritas inks distro deal in Australia, New Zealand for V-Go insulin delivery device appeared first on MassDevice.
